Regenerative Therapy for Cartilage Damage

Description:
The subject technology discloses a tissue engineering method for treating cartilage damage. Stem cells from bone marrow are attached to a novel scaffold, hyaluronic acid-coated fibrin microbeads, and transferred to a live host to form cartilage. The regenerated cartilage is stable and not hypertrophic, which has been problematic in the current regenerative methods.
Patent Information:
For Information, Contact:
Vladimir Knezevic
Senior Advisor for Commercial Evaluations
NIH Technology Transfer
vlado.knezevic@nih.gov
Inventors:
Mitchell Shirvan
Rafael Gorodetsky
Sergei Kuznetsov
Astar Lazmi-Hailu
Pamela Robey
Keywords:
Bone
Cartilage
Cells
Fibrin
Generation
Human
Hyaline
Marrow
Microbeads
STABLE
Stromal
TRANSPLANTATION
VAXXXX
Vivo
WJXXXX
XCXXXX
XDXXXX
YAXXXX
YBXXXX
YCXXXX
© 2024. All Rights Reserved. Powered by Inteum